is semaglutide being banned in the us FDA Warns on Certain Forms of Compounded What to know about the

announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise

This is the pea-sized gland found at the base of the brain that is responsible for regulating an organisms endocrine-based functionality

Side effects can range from uncomfortable to severe and, in some cases, life-threatening

Do not use WEGOVY if: you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)